Literature DB >> 30895419

Recent advances in the diagnosis and treatment of Coats' disease.

Xinyue Yang1, Chenguang Wang1, Guanfang Su2.   

Abstract

PURPOSE: To review and summarize the recent progress in the diagnosis and treatment of Coats' disease.
METHODS: Literature was collected from Web of Science, Medline and Pubmed, through searching of these keywords: "Coats' disease", "diagnosis" and "treatment".
RESULTS: Coats' disease is characterized by idiopathic leaky retinal vascular telangiectasia and microvascular abnormalities often accompanied by intraretinal or subretinal exudation and retinal detachment. Neovascular glaucoma and phthisis bulbi often occur in advanced cases. Coats' disease has significant diversity in terms of its clinical presentation and morphology. Anti-VEGF therapy combined with laser photocoagulation for early Coats' disease and anti-VEGF therapy combined with minimally invasive vitrectomy for advanced Coats' disease can achieve good efficacy.
CONCLUSION: Early diagnosis and timely treatment based on clinical stage are critical to retaining the patient's visual function. Patients should be aware that close long-term follow-up is necessary.

Entities:  

Keywords:  Coats’ disease; Diagnosis; Treatment; VEGF

Mesh:

Substances:

Year:  2019        PMID: 30895419     DOI: 10.1007/s10792-019-01095-8

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  Fovea-threatening and fovea-involving peripheral Coats disease: effects of posture and intervention.

Authors:  Eduardo Cunha de Souza; Evandro Rosa; João Rafael de Oliveira Dias; Fernando Korn Malerbi; Bruno Campelo Leal; Helio Paulo Primiano Junior
Journal:  Int J Retina Vitreous       Date:  2022-06-17

2.  Long-term follow-up of a case of Coats disease in a 10-year-old boy with spontaneous peeling of preretinal macular fibrosis: a case report.

Authors:  Tomoka Mizobuchi; Takashi Nishiuchi; Yusaku Miura; Ken Fukuda
Journal:  BMC Ophthalmol       Date:  2022-04-27       Impact factor: 2.086

3.  Optical Coherence Tomography Angiography Findings After Intravitreal Ranibizumab in Patients With Coats Disease.

Authors:  Gilda Cennamo; Daniela Montorio; Chiara Comune; Maria Paola Laezza; Matteo Fallico; Maria Elena Lionetti; Michele Reibaldi
Journal:  Front Med (Lausanne)       Date:  2021-01-21

4.  Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats' Disease.

Authors:  Mohamed Nowara; Yousef A Fouad; Ihab Abdel Aziz; Ahmed M Habib; Mariam Al-Feky; Hisham Hassan
Journal:  Clin Ophthalmol       Date:  2021-01-29

5.  Clinical features and prognostic factors in 71 eyes over 20 years from patients with Coats' disease in Korea.

Authors:  Hyun Goo Kang; Jung Dong Kim; Eun Young Choi; Suk Ho Byeon; Sung Soo Kim; Hyoung Jun Koh; Min Kim
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

6.  Rhegmatogenous retinal detachment in Coats' disease: a case report.

Authors:  Simanta Khadka; Raghunandan Byanju; Sabina Parajuli
Journal:  J Med Case Rep       Date:  2021-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.